NCT07188194View on ClinicalTrials.gov

ADAM'S Prognostic Markers

Not yet recruitingOBSERVATIONAL

Enrollment

32

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

October 31, 2026

Conditions

Acute Disseminated Encephalomyelitis

All Listed Sponsors

lead

Assiut University

OTHER

NCT07188194 - ADAM'S Prognostic Markers | Biotech Hunter | Biotech Hunter